Uncommon Pathways of Immune Escape Attenuate HIV-1 Integrase Replication Capacity

ABSTRACT An attenuation of the HIV-1 replication capacity (RC) has been observed for immune-mediated escape mutations in Gag restricted by protective HLA alleles. However, the extent to which escape mutations affect other viral proteins during natural infection is not well understood. We generated recombinant viruses encoding plasma HIV-1 RNA integrase sequences from antiretroviral-naïve individuals with early (n = 88) and chronic (n = 304) infections and measured the in vitro RC of each. In contrast to data from previous studies of Gag, we observed little evidence that host HLA allele expression was associated with integrase RC. A modest negative correlation was observed between the number of HLA-B-associated integrase polymorphisms and RC in chronic infection (R = −0.2; P = 0.003); however, this effect was not driven by mutations restricted by protective HLA alleles. Notably, the integrase variants S119R, G163E, and I220L, which represent uncommon polymorphisms associated with HLA-C*05, -A*33, and -B*52, respectively, correlated with lower RC (all q < 0.2). We identified a novel C*05-restricted epitope (HTDNGSNF114–121) that likely contributes to the selection of the S119R variant, the polymorphism most significantly associated with lower RC in patient sequences. An NL4-3 mutant encoding the S119R polymorphism displayed a ∼35%-reduced function that was rescued by a single compensatory mutation of A91E. Together, these data indicate that substantial HLA-driven attenuation of integrase is not a general phenomenon during HIV-1 adaptation to host immunity. However, uncommon polymorphisms selected by HLA alleles that are not conventionally regarded to be protective may be associated with impaired protein function. Vulnerable epitopes in integrase might therefore be considered for future vaccine strategies.

[1]  Todd M. Allen,et al.  Definition of the viral targets of protective HIV-1-specific T cell responses , 2011, Journal of Translational Medicine.

[2]  D. Heckerman,et al.  Translation of HLA–HIV Associations to the Cellular Level: HIV Adapts To Inflate CD8 T Cell Responses against Nef and HLA-Adapted Variant Epitopes , 2011, The Journal of Immunology.

[3]  R. Siliciano,et al.  Viral suppression of multiple escape mutants by de novo CD8+ T cell responses in a human immunodeficiency virus-1 Infected elite suppressor , 2011, Retrovirology.

[4]  E. Arts,et al.  HIV-1 replicative fitness in elite controllers , 2011, Current opinion in HIV and AIDS.

[5]  M. Churchill,et al.  The Sydney Blood Bank Cohort: implications for viral fitness as a cause of elite control , 2011, Current opinion in HIV and AIDS.

[6]  Sebastian Bonhoeffer,et al.  A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase , 2011, Nature Genetics.

[7]  David Heckerman,et al.  Progression to AIDS in South Africa Is Associated with both Reverting and Compensatory Viral Mutations , 2011, PloS one.

[8]  P. Cherepanov,et al.  Structural insights into the retroviral DNA integration apparatus. , 2011, Current opinion in structural biology.

[9]  A. Engelman,et al.  Structural biology of retroviral DNA integration. , 2011, Virology.

[10]  D. Hazuda,et al.  Raltegravir: the first HIV‐1 integrase strand transfer inhibitor in the HIV armamentarium , 2011, Annals of the New York Academy of Sciences.

[11]  Todd M. Allen,et al.  Reduced Replication Capacity of NL4-3 Recombinant Viruses Encoding Reverse Transcriptase–Integrase Sequences From HIV-1 Elite Controllers , 2011, Journal of acquired immune deficiency syndromes.

[12]  W. Powderly Integrase inhibitors in the treatment of HIV-1 infection. , 2010, The Journal of antimicrobial chemotherapy.

[13]  Goedele N. Maertens,et al.  The mechanism of retroviral integration through X-ray structures of its key intermediates , 2010, Nature.

[14]  D. Kuritzkes,et al.  Effect of Raltegravir Resistance Mutations in HIV-1 Integrase on Viral Fitness , 2010, Journal of acquired immune deficiency syndromes.

[15]  Todd M. Allen,et al.  Early Selection in Gag by Protective HLA Alleles Contributes to Reduced HIV-1 Replication Capacity That May Be Largely Compensated for in Chronic Infection , 2010, Journal of Virology.

[16]  David Heckerman,et al.  Gag-Protease-Mediated Replication Capacity in HIV-1 Subtype C Chronic Infection: Associations with HLA Type and Clinical Parameters , 2010, Journal of Virology.

[17]  S. Buus,et al.  Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B*2705-Restricted CD8+ T Cells , 2010, Journal of Virology.

[18]  E. Rosenberg,et al.  Impaired Replication Capacity of Acute/Early Viruses in Persons Who Become HIV Controllers , 2010, Journal of Virology.

[19]  P. Goulder,et al.  Long-Term Control of HIV-1 in Hemophiliacs Carrying Slow-Progressing Allele HLA-B*5101 , 2010, Journal of Virology.

[20]  B. Clotet,et al.  The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates , 2010, AIDS.

[21]  David W. Haas,et al.  HLA-Associated Immune Escape Pathways in HIV-1 Subtype B Gag, Pol and Nef Proteins , 2009, PloS one.

[22]  Anthony D. Kelleher,et al.  Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4+ T Cells , 2009, Journal of Virology.

[23]  Eric J. Arts,et al.  Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response , 2009, PLoS pathogens.

[24]  M. Essex,et al.  Reduced Viral Replication Capacity of Human Immunodeficiency Virus Type 1 Subtype C Caused by Cytotoxic-T-Lymphocyte Escape Mutations in HLA-B57 Epitopes of Capsid Protein , 2008, Journal of Virology.

[25]  Todd M. Allen,et al.  HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1 , 2008, Journal of Virology.

[26]  Philip J. R. Goulder,et al.  Functional Consequences of Human Immunodeficiency Virus Escape from an HLA-B*13-Restricted CD8+ T-Cell Epitope in p1 Gag Protein , 2008, Journal of Virology.

[27]  Tommy F. Liu,et al.  Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors , 2008, Retrovirology.

[28]  David Heckerman,et al.  Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection , 2008, Journal of Virology.

[29]  David Heckerman,et al.  Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients , 2008, The Journal of experimental medicine.

[30]  Tanmoy Bhattacharya,et al.  HLA Class I-Driven Evolution of Human Immunodeficiency Virus Type 1 Subtype C Proteome: Immune Escape and Viral Load , 2008, Journal of Virology.

[31]  Winston A Hide,et al.  Transmission of HIV-1 CTL Escape Variants Provides HLA-Mismatched Recipients with a Survival Advantage , 2008, PLoS pathogens.

[32]  S. Oka,et al.  CTL-Mediated Selective Pressure Influences Dynamic Evolution and Pathogenic Functions of HIV-1 Nef1 , 2008, The Journal of Immunology.

[33]  M. Quiñones-Mateu,et al.  Viral drug resistance and fitness. , 2008, Advances in pharmacology.

[34]  Todd M. Allen,et al.  Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication , 2007, Journal of Virology.

[35]  Nebojsa Jojic,et al.  Extensive HLA class I allele promiscuity among viral CTL epitopes , 2007, European journal of immunology.

[36]  Todd M. Allen,et al.  Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A , 2007, Journal of Virology.

[37]  David Heckerman,et al.  Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 , 2007, PLoS pathogens.

[38]  P. Harrigan,et al.  Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy. , 2007, The Journal of infectious diseases.

[39]  D. Heckerman,et al.  Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations , 2007, Science.

[40]  C. Boutwell,et al.  Identification of HLA class I-associated amino acid polymorphisms in the HIV-1C proteome. , 2007, AIDS research and human retroviruses.

[41]  F. Pereyra,et al.  Control of Human Immunodeficiency Virus Type 1 Is Associated with HLA-B*13 and Targeting of Multiple Gag-Specific CD8+ T-Cell Epitopes , 2007, Journal of Virology.

[42]  David Heckerman,et al.  CD8+ T-cell responses to different HIV proteins have discordant associations with viral load , 2007, Nature Medicine.

[43]  David C. Nickle,et al.  Selection on the Human Immunodeficiency Virus Type 1 Proteome following Primary Infection , 2006, Journal of Virology.

[44]  Todd M. Allen,et al.  HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8+ T Cell Response against HIV-1 , 2006, PLoS medicine.

[45]  B. Walker,et al.  The challenges of host and viral diversity in HIV vaccine design. , 2006, Current opinion in immunology.

[46]  David Heckerman,et al.  Leveraging Information Across HLA Alleles/Supertypes Improves Epitope Prediction , 2006, RECOMB.

[47]  B. Walker,et al.  Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.

[48]  Todd M. Allen,et al.  Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry. , 2006, Journal of virological methods.

[49]  Christian Brander,et al.  Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution , 2005, Journal of Virology.

[50]  D. Heckerman,et al.  Leveraging Information Across HLA Alleles/Supertypes Improves HLA-Specific Epitope Prediction , 2005 .

[51]  O. Lund,et al.  An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions , 2005, European journal of immunology.

[52]  R. Hogg,et al.  Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users. , 2004, International journal of epidemiology.

[53]  Norman L. Letvin,et al.  Fitness Costs Limit Viral Escape from Cytotoxic T Lymphocytes at a Structurally Constrained Epitope , 2004, Journal of Virology.

[54]  E. Rosenberg,et al.  CD8+ T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjects , 2004, Journal of Translational Medicine.

[55]  F. M. Marincola,et al.  Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities , 2004, Journal of Virology.

[56]  John Sidney,et al.  Reversion of CTL escape–variant immunodeficiency viruses in vivo , 2004, Nature Medicine.

[57]  Mark A Wainburg The impact of the M184V substitution on drug resistance and viral fitness , 2004 .

[58]  M. Wainberg The impact of the M184V substitution on drug resistance and viral fitness. , 2004, Expert review of anti-infective therapy.

[59]  O. Gascuel,et al.  A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. , 2003, Systematic biology.

[60]  Michael P Busch,et al.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.

[61]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Sudoł,et al.  An Amino Acid in the Central Catalytic Domain of Three Retroviral Integrases That Affects Target Site Selection in Nonviral DNA , 2003, Journal of Virology.

[63]  Søren Brunak,et al.  Clustering Patterns of Cytotoxic T-Lymphocyte Epitopes in Human Immunodeficiency Virus Type 1 (HIV-1) Proteins Reveal Imprints of Immune Evasion on HIV-1 Global Variation , 2002, Journal of Virology.

[64]  Wei Yang,et al.  Structure of a two‐domain fragment of HIV‐1 integrase: implications for domain organization in the intact protein , 2001, The EMBO journal.

[65]  R M Stroud,et al.  Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[66]  S. Oka,et al.  Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules. , 1999, Human immunology.

[67]  G A Satten,et al.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. , 1998, JAMA.

[68]  J. Zhang,et al.  Methods for comparing a DNA sequence with a protein sequence , 1996, Comput. Appl. Biosci..